AI assistant
Advanced Enzyme Technologies Limited — Regulatory Filings 2021
Sep 28, 2021
62369_rns_2021-09-28_0c2a28ca-a394-45b2-80cd-26f00e9d0995.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
September 28, 2021
BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, Exchange Plaza, Plot No. C/1, G Block Mumbai-400 001 Bandra-Kurla Complex, Bandra (E) Scrip ID-540025 Mumbai-400 051 Scrip Code-ADVENZYMES
Dear Sir/Madam,
Sub: Intimation of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
We wish to inform you that pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst / Investor Meetings with the Company is as under:
| Date | Interaction With | Type |
|---|---|---|
| October 01, 2021 | Motilal Oswal’s Biotech and Medtech Day | Virtual, Groupmeeting |
Note: The aforesaid is subject to change. Changes may happen due to exigencies on the part of Fund/Company.
The aforesaid information is also being uploaded on the Company’s website.
You are requested to kindly take a note of the same.
Thanking you, Yours faithfully,
For Advanced Enzyme Technologies Limited
SANJAY Digitally signed by SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2021.09.28 17:13:20 +05'30'
Sanjay Basantani
Company Secretary and Head – Legal